Other Neuroendocrine Tumors of Head and Neck Region



Fig. 16.1
Well-differentiated neuroendocrine tumor of the right middle ear detected by fused somatostatin receptor PET/CT. PET with somatostatin analogs labeled with gallium-68 (upper row) detected a focal area of increased radiopharmaceutical uptake (arrows) corresponding to a subcentimeter nodule in the right middle ear at CT (mid row) and fused PET/CT images (lower row)



A325225_1_En_16_Fig2_HTML.jpg


Fig. 16.2
Sinonasal small cell carcinoma of the left ethmoidal sinus (arrows) imaged by fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) in sagittal (a) and axial projection (b), magnetic resonance imaging (MRI) in axial projection (c), and fused PET/MRI (d). This tumor was well-characterized by MRI which showed invasion of the adjacent structures. PET demonstrated increased glucose metabolism of this tumor without metastatic spread


A325225_1_En_16_Fig3_HTML.jpg


Fig. 16.3
Metastatic laryngeal small cell carcinoma imaged by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). 18F-FDG PET (a) showed an area of increased tracer uptake corresponding to a laryngeal tumor (red arrow) at CT (c1) and fused PET/CT images in sagittal (b) and axial projection (c2). Furthermore several right cervical lymph nodal metastases (yellow arrows) were detected by PET (a), CT (c1, d1), and fused PET/CT images (c2, d2). Interestingly, 18F-FDG PET detected bone metastases (green arrows) without significant morphological abnormalities at co-registered CT (e1, e2)
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 4, 2016 | Posted by in HEAD AND NECK SURGERY | Comments Off on Other Neuroendocrine Tumors of Head and Neck Region

Full access? Get Clinical Tree

Get Clinical Tree app for offline access